Loading clinical trials...
Loading clinical trials...
A Pilot Study Evaluating the Utility of 18F-DOPA PET for Radiotherapy Treatment Planning of Malignant Glioma Patients
Conditions
Interventions
Fluorine-18-L-dihydroxyphenylalanine
Locations
1
United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
April 8, 2014
Primary Completion Date
March 26, 2021
Completion Date
March 1, 2031
Last Updated
April 6, 2026
NCT05099003
NCT05278208
NCT05717153
NCT03155620
NCT03213652
NCT04195555
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions